Group Pharmaceuticals Limited - Company Profile

Q: Where is Group Pharmaceuticals Limited headquartered?

Group Pharmaceuticals Limited is headquartered at W-46 B M I D Ctarapur Industrial Area, Thane, Maharashtra, 401506.

Q: Who are the current directors of Group Pharmaceuticals Limited?

The current directors of Group Pharmaceuticals Limited are Deepak Mohan, Sunil Attavar Cajaten, Ann Valerie Sunil Attavar, Srinivas Gogineni, Nandipur Kallappa Dilip, Jacob Mathew, Nikhil Kaushik, Vineeth Gururaj Kulkarni.

It is a pharma public limited company based in Thane, Maharashtra, India, established in 1980.

1980 Thane, Maharashtra, India Active

Last Updated: December 18, 2025

Access Report

About Group Pharmaceuticals Limited

Group Pharmaceuticals Limited, a active public limited company, was established on 24 July 1980 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1980PLC022889. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹12.68 Cr.

Formerly known as Group Pharmaceuticals Private Limited. It upholds a compliant status. Employing 739 professional, Its leadership includes Deepak Mohan (Managing Director), Sunil Attavar Cajaten (Nodal Officer), Ann Valerie Sunil Attavar (Whole-Time Director). Past directors included Deepak Mohan, Sunil Attavar Cajaten, Gopal Singh. It holds ₹20.00 Cr open charges and ₹31.62 Cr settled loans. Its latest AGM occurred on 26 July 2025, with the balance sheet filed on 31 March 2025. It is based at W-46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, 401506.

Company Details

CIN/LLPIN
U24239MH1980PLC022889
Registration Number
022889
Incorporation Date
24 July 1980
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹12.68 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 18-12-2025
Paid Up Capital ₹ 12.68 Cr as on 18-12-2025
Company Age 45 Year, 6 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 20.00 Cr as on 18-12-2025
Satisfied Charges ₹ 31.62 Cr as on 18-12-2025
Revenue Growth **** 14.38% (FY 2024)
Profit Growth **** 120.66% (FY 2024)
Ebitda **** 81.58% (FY 2024)
Net Worth 19.55% (FY 2024)
Total Assets **** 17.15% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Group Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Group Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Deepak Mohan	Managing Director	24 May 2024	Current
Sunil Attavar Cajaten	Nodal Officer	17 Sep 2019	Current
Ann Valerie Sunil Attavar	Whole-Time Director	15 Sep 2008	Current
Srinivas Gogineni	Director	08 Aug 2024	Current
Nandipur Kallappa Dilip	Director	08 Aug 2024	Current
Jacob Mathew	Director	24 May 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	07 Aug 2024	Past
Pramod Abcsdd	Whole-Time Director	15 Sep 2008	Past
Pramod Abcsdd	Whole-Time Director	24 May 2024	Past
Pramod Abcsdd	Additional Director	27 Sep 2019	Past
Pramod Abcsdd	Whole-Time Director	10 Mar 2013	Past
Pramod Abcsdd	Additional Director	27 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Group Pharmaceuticals.

Group Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.38% increase. The company also saw a substantial improvement in profitability, with a 120.66% increase in profit. The company's net worth Soared by an impressive increase of 19.55%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

14.38%

*******

Revenue from Operations

*******

14.07%

*******

Total Assets

*******

17.15%

*******

Profit or Loss

*******

120.66%

*******

Net Worth

*******

19.55%

*******

EBITDA

*******

81.58%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Group Pharmaceuticals?

In 2024, Group Pharmaceuticals had a promoter holding of 62.02% and a public holding of 37.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹200,000,000.00

Satisfied Charges

₹316,165,000.00

Charges Breakdown by Lending Institutions

Others : 20.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Oct 2025	Others	₹20.00 Cr	Open
04 Mar 2005	Others	₹16.25 Cr	Satisfied
27 Mar 2002	Central Bank Of India	₹5.50 Cr	Satisfied
04 Aug 2001	Central Bank Of India	₹0.00	Satisfied
12 Jul 1999	Central Bank Of India	₹0.00	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Group Pharmaceuticals?

Group Pharmaceuticals has a workforce of 739 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Group Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Group Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Group Pharmaceuticals

Recent Activity within the Organization

Charges

A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101182496 was registered on 28 Oct 2025. was recorded as a recent event.
28 Oct 2025
Director Appointment

Progress on Nikhil Kaushik was appointed as a Additional Director was appointed as a Additional Director on 29 Sep 2025 & has been associated with this company since 4 months 15 days . was documented.
29 Sep 2025
Annual General Meeting

Progress on Group Pharmaceuticals Limited last Annual general meeting of members was held on 26 Jul 2025 as per latest MCA records. was documented.
26 Jul 2025
Director Appointment

The activity Nikhil Kaushik was appointed as a Ceo was appointed as a Ceo on 28 May 2025 & has been associated with this company since 8 months 16 days . was completed.
28 May 2025
Director Appointment

Vineeth Gururaj Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 28 May 2025 & has been associated with this company since 8 months 16 days . was recorded as a recent event.
28 May 2025
Balance Sheet

Group Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025

Explore recent activity and updates - View Recent Activity